These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8001283)

  • 1. Biochemical studies in head and neck cancer.
    Lal H
    Clin Biochem; 1994 Aug; 27(4):235-43. PubMed ID: 8001283
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating markers in squamous cell carcinoma of the head and neck: a review.
    Rassekh CH; Johnson JT; Eibling DE
    Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):23-8. PubMed ID: 9135969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum SCC-Ag in head and neck squamous cell carcinoma.
    Palermo F; Carniato A; Fede A; Boccaletto F; Marchiori C
    Int J Biol Markers; 1990; 5(3):118-20. PubMed ID: 2286775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of tissue polypeptide antigen (TPA) in head and neck carcinomas.
    Becciolini A; Porciani S; Lanini A; Tommasi M; Olmi P; Chiavacci A
    Acta Oncol; 1993; 32(3):295-9. PubMed ID: 8323767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical value of head and neck tumor markers].
    Gascón Vilaplana P
    Med Clin (Barc); 2007 Dec; 129(20):775-6. PubMed ID: 18093479
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum tumor markers of head and neck cancer: current status.
    Hanna EY; Papay FA; Gupta MK; Lavertu P; Tucker HM
    Head Neck; 1990; 12(1):50-9. PubMed ID: 2404906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous cell carcinoma antigen in serum for monitoring of head and neck and uterine cervical squamous cell carcinomas after radiotherapy.
    Shirato H; Ichimura W; Wakushima H; Nishioka T; Suzuki K
    Acta Oncol; 1993; 32(6):663-6. PubMed ID: 8260185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of intercellular adhesion molecule-1 in squamous cell carcinoma of the head and neck.
    Wollenberg B; Jan N; Sautier W; Hofmann K; Schmitt UM; Stieber P
    Tumour Biol; 1997; 18(2):88-94. PubMed ID: 9222306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme immunoassay for serum autoantibody to survivin and its findings in head-and-neck cancer patients.
    Chang JT; Wong FH; Liao CT; Chen IH; Wang HM; Cheng AJ
    Clin Chem; 2004 Jul; 50(7):1261-4. PubMed ID: 15229162
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic significance of SCC antigen in the serum of patients with head and neck cancer.
    Molina R; Torres MD; Moragas M; Perez-Villa J; Filella X; Jo J; Farrus B; Giménez N; Traserra J; Ballesta AM
    Tumour Biol; 1996; 17(2):81-9. PubMed ID: 8658017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis of radiotherapy failure for patients with head and neck cancer: the role of biochemical markers.
    Mrochem-Kwarciak J; Rutkowski T; Wygoda A; Deja R; Hajduk A; Składowski K
    Tumori; 2018 Aug; 104(4):273-279. PubMed ID: 28604997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue and plasma fibronectin level in patients with head and neck carcinoma.
    Baskin Y; Kirkali G; Güner G; Sengör T; Ceryan K
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):308S. PubMed ID: 8224453
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue and plasma elastase and anti-protease (alpha 1 protease inhibitor-alpha 2 macroglobulin) levels in malignancies of head and neck.
    Kirkali G; Baskin Y; Güner G; Sengör T; Ceryan K
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):307S. PubMed ID: 7693524
    [No Abstract]   [Full Text] [Related]  

  • 16. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125.
    Straka MB; Wagner RL; Johnson JT; Kachman KK; Eibling DE
    Arch Otolaryngol Head Neck Surg; 1992 Aug; 118(8):802-5. PubMed ID: 1642830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reappraisal of the squamous cell carcinoma antigen as a tumor marker in head and neck cancer.
    Snyderman CH; D'Amico F; Wagner R; Eibling DE
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1294-7. PubMed ID: 7576477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of Cyfra 21-1 as a new tumor marker for the diagnosis of epidermoid carcinoma of the head and neck].
    González Sánchez E; López-Ríos Velasco J; Calvo Boizas E; García-Talavera Fernández JR; Martín Ro-dríguez M; Muñoz Herrera A; Del Cañizo Alvarez A
    Acta Otorrinolaringol Esp; 1999 Mar; 50(2):85-9. PubMed ID: 10217679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma.
    Kimura Y; Fujieda S; Takabayashi T; Tanaka T; Sugimoto C; Saito H
    Cancer Lett; 2000 Jul; 155(2):163-8. PubMed ID: 10822131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte polyamine determinations in patients with head and neck cancer.
    Shideler CE; Johns ME; Cantrell RW; Shipe JR; Wills MR; Savory J
    Arch Otolaryngol; 1981 Dec; 107(12):752-4. PubMed ID: 7316857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.